V-Wave is focused on developing percutaneous implantable devices for treating patients with chronic heart failure.

The companys vision is to help patients with disabling symptoms or who need hospitalization despite optimized medical treatment.V-Wave has developed the V-Wave Shunt, a miniature, biocompatible implant that regulates left atrial pressure (LAP), a primary cause of worsening symptoms that lead to over three million hospitalizations a year.

The proprietary, unidirectional, interatrial shunt is designed to prevent episodes of elevated LAP, thereby improving symptoms, reducing hospitalizations, and increasing exercise tolerance and quality of life.